Showing results (331-340 of 347) with videos related to
Sort By:
Pageof 35
Translational Research : the Journal of Laboratory and Clinical Medicine|January 2, 2018
Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosisAyse L Mindikoglu, Antone R Opekun, Nagireddy Putluri, et al.JAMA Network Open|February 17, 2026
Chronic Kidney Disease Severity and Risk of Cognitive ImpairmentZhijie Huang, Kristine Yaffe, Changwei Li, et al.The American Journal of Medicine|May 26, 2025
Higher Risk of Kidney Failure Associated With Angiotensin Receptor Blockers vs ACE Inhibitors in Patients With Heart FailureHans J Moore, Wen-Chih Wu, Paul A Heidenreich, et al.European Heart Journal|May 17, 2024
Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratificationRuth F Dubin, Rajat Deo, Yue Ren, et al.Journal of the American College of Cardiology|September 25, 2024
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and HyperkalemiaBertram Pitt, Stefan D Anker, Lars H Lund, et al.European Journal of Heart Failure|July 3, 2025
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND studyAndreas P Kalogeropoulos, Ishaque Hameed, Stefan D Anker, et al.American Heart Journal|April 29, 2008
The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart StudyBraxton D Mitchell, Patrick F McArdle, Haiqing Shen, et al.Journal of Diabetes and Its Complications|December 19, 2021
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseasesYehuda Handelsman, John E Anderson, George L Bakris, et al.Nature Genetics|September 17, 2008
MYH9 is associated with nondiabetic end-stage renal disease in African AmericansW H Linda Kao, Michael J Klag, Lucy A Meoni, et al.European Heart Journal|July 28, 2022
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trialJaved Butler, Stefan D Anker, Lars H Lund, et al.Pageof 35